LENSAR (NASDAQ:LNSR) Releases Earnings Results, Misses Expectations By $0.02 EPS

Key Points

• LENSAR missed earnings and revenue estimates: Reported EPS of ($0.12) vs. a consensus ($0.10) (miss of $0.02) and revenue of $16.03 million versus analysts' $20.30 million estimate.
• Shares trade near yearly lows and carry a small market cap: Stock opened at $5.87 (1‑year range $5.35–$14.31) with a market cap of $70.09 million and a negative trailing P/E of -1.34.
• Mixed investor interest and analyst views: Institutional ownership is about 40.15% with several recent new/expanded stakes, while analyst coverage is split (one Buy, one Sell) yielding an average rating of "Hold."

LENSAR (NASDAQ:LNSR - Get Free Report) announced its earnings results on Tuesday. The company reported ($0.12) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.02), FiscalAI reports. The company had revenue of $16.03 million during the quarter, compared to analyst estimates of $20.30 million.

LENSAR Stock Performance

Shares of LENSAR stock opened at $5.87 on Tuesday. LENSAR has a 1 year low of $5.35 and a 1 year high of $14.31. The firm's 50-day simple moving average is $10.82 and its 200-day simple moving average is $11.31. The firm has a market cap of $70.09 million, a PE ratio of -1.34 and a beta of 0.66.

Institutional Trading of LENSAR

Hedge funds and other institutional investors have recently bought and sold shares of the company. Rangeley Capital LLC bought a new position in LENSAR during the 2nd quarter worth approximately $658,000. Dynamic Technology Lab Private Ltd increased its holdings in shares of LENSAR by 436.6% in the 4th quarter. Dynamic Technology Lab Private Ltd now owns 54,166 shares of the company's stock valued at $630,000 after acquiring an additional 44,072 shares during the last quarter. Goldman Sachs Group Inc. bought a new stake in shares of LENSAR in the 1st quarter valued at approximately $546,000. Acadian Asset Management LLC acquired a new stake in shares of LENSAR during the 1st quarter valued at approximately $257,000. Finally, One68 Global Capital LLC bought a new position in LENSAR during the third quarter worth $214,000. 40.15% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on LNSR shares. Weiss Ratings restated a "sell (d-)" rating on shares of LENSAR in a research note on Thursday, January 22nd. BTIG Research raised LENSAR from a "neutral" rating to a "buy" rating in a research report on Tuesday, March 17th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, the stock presently has an average rating of "Hold".

LENSAR Company Profile

LENSAR, Inc, headquartered in Orlando, Florida, is a medical technology company specializing in advanced laser systems for ophthalmic surgery. Its flagship product, the LENSAR Laser System, combines proprietary three-dimensional imaging with precision-guided femtosecond laser delivery to perform critical steps in cataract procedures, including capsulotomy creation, lens fragmentation and corneal incisions.

Founded in 2005, LENSAR has concentrated its research and development efforts on enhancing surgical accuracy and patient outcomes in cataract treatment.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.